You pull up to the drive-thru, still not very hungry thanks to the weekly shot your doctor prescribed. A combo meal feels like too much, but you don’t want to skip lunch. Restaurants have noticed people like you, and menus are starting to change because of it.
Key Takeaways
- About 1 in 9 U.S. adults now take a GLP-1 drug for weight loss. That’s 11% in 2026, up from 3% in 2024, according to Gallup. These drugs, such as Ozempic, Wegovy and Zepbound, curb appetite, so people eat less.
- Fast food chains are responding with smaller portions and protein-forward items: bowls, wraps, egg bites, bite-sized burgers and mini protein bowls.
- McDonald’s announced an $8.5 billion, 10-year plan in September 2026. It’s mostly a restaurant modernization effort, and it includes new protein-focused menu items aimed partly at GLP-1 users.
- Protein matters on these drugs. In one major trial, about 40% of the weight people lost was lean mass, not fat. Experts recommend getting enough protein and doing strength training to protect muscle.
- “High protein” doesn’t automatically mean healthy. Fast food items can still be heavy in sodium and low in fiber, so the rest of the meal matters.